189 related articles for article (PubMed ID: 12153755)
1. Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats.
Saghir SA; Schultz IR
Environ Health Perspect; 2002 Aug; 110(8):757-63. PubMed ID: 12153755
[TBL] [Abstract][Full Text] [Related]
2. Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: dose-response relationships and age as a modifying factor.
Schultz IR; Merdink JL; Gonzalez-Leon A; Bull RJ
Toxicology; 2002 May; 173(3):229-47. PubMed ID: 11960676
[TBL] [Abstract][Full Text] [Related]
3. Stereospecific toxicokinetics of bromochloro- and chlorofluoroacetate: effect of GST-zeta depletion.
Schultz IR; Sylvester SR
Toxicol Appl Pharmacol; 2001 Sep; 175(2):104-13. PubMed ID: 11543642
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water.
Gonzalez-Leon A; Schultz IR; Xu G; Bull RJ
Toxicol Appl Pharmacol; 1997 Oct; 146(2):189-95. PubMed ID: 9344886
[TBL] [Abstract][Full Text] [Related]
5. Toxicokinetics and oral bioavailability of halogenated acetic acids mixtures in naïve and GSTzeta-depleted rats.
Saghir SA; Schultz IR
Toxicol Sci; 2005 Apr; 84(2):214-24. PubMed ID: 15625187
[TBL] [Abstract][Full Text] [Related]
6. A quantitative description of suicide inhibition of dichloroacetic acid in rats and mice.
Keys DA; Schultz IR; Mahle DA; Fisher JW
Toxicol Sci; 2004 Dec; 82(2):381-93. PubMed ID: 15375292
[TBL] [Abstract][Full Text] [Related]
7. Effects of Multiple Doses of Dichloroacetate on GSTZ1 Expression and Activity in Liver and Extrahepatic Tissues of Young and Adult Rats.
Squirewell EJ; Smeltz MG; Rowland-Faux L; Horne LP; Stacpoole PW; James MO
Drug Metab Dispos; 2020 Nov; 48(11):1217-1223. PubMed ID: 32873593
[TBL] [Abstract][Full Text] [Related]
8. Effect of pre-treatment with dichloroacetic or trichloroacetic acid in drinking water on the pharmacokinetics of a subsequent challenge dose in B6C3F1 mice.
Gonzalez-Leon A; Merdink JL; Bull RJ; Schultz IR
Chem Biol Interact; 1999 Dec; 123(3):239-53. PubMed ID: 10654841
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice.
Larson JL; Bull RJ
Toxicol Appl Pharmacol; 1992 Aug; 115(2):268-77. PubMed ID: 1641860
[TBL] [Abstract][Full Text] [Related]
10. Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal.
Guo X; Dixit V; Liu H; Shroads AL; Henderson GN; James MO; Stacpoole PW
Drug Metab Dispos; 2006 Jan; 34(1):36-42. PubMed ID: 16199472
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of dichloroacetic acid kinetics in human--a physiologically based pharmacokinetic modeling investigation.
Li T; Schultz I; Keys DA; Campbell JL; Fisher JW
Toxicology; 2008 Mar; 245(1-2):35-48. PubMed ID: 18242812
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate.
Tzeng HF; Blackburn AC; Board PG; Anders MW
Chem Res Toxicol; 2000 Apr; 13(4):231-6. PubMed ID: 10775321
[TBL] [Abstract][Full Text] [Related]
13. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat.
DeAngelo AB; Daniel FB; Most BM; Olson GR
Toxicology; 1996 Dec; 114(3):207-21. PubMed ID: 8980710
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking alpha-haloalkanoic acids.
Anderson WB; Board PG; Gargano B; Anders MW
Chem Res Toxicol; 1999 Dec; 12(12):1144-9. PubMed ID: 10604862
[TBL] [Abstract][Full Text] [Related]
15. A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats.
Jiang Y; Milavetz G; James MO; An G
J Pharm Sci; 2017 May; 106(5):1396-1404. PubMed ID: 28163135
[TBL] [Abstract][Full Text] [Related]
16. Exposure of Rats to Multiple Oral Doses of Dichloroacetate Results in Upregulation of Hepatic Glutathione Transferases and NAD(P)H Dehydrogenase [Quinone] 1.
Squirewell EJ; Mareus R; Horne LP; Stacpoole PW; James MO
Drug Metab Dispos; 2020 Nov; 48(11):1224-1230. PubMed ID: 32873592
[TBL] [Abstract][Full Text] [Related]
17. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses.
Curry SH; Lorenz A; Chu PI; Limacher M; Stacpoole PW
Biopharm Drug Dispos; 1991 Jul; 12(5):375-90. PubMed ID: 1878534
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and effects of dichloroacetic acid in rainbow trout.
Fitzsimmons PN; Hoffman AD; Lien GJ; Hammermeister DE; Nichols JW
Aquat Toxicol; 2009 Sep; 94(3):186-94. PubMed ID: 19656582
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic considerations with dichloroacetate dosing.
James MO; Stacpoole PW
Pharmacogenomics; 2016 May; 17(7):743-53. PubMed ID: 27143230
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oral dichloroacetate in dogs.
Maisenbacher HW; Shroads AL; Zhong G; Daigle AD; Abdelmalak MM; Samper IS; Mincey BD; James MO; Stacpoole PW
J Biochem Mol Toxicol; 2013 Dec; 27(12):522-5. PubMed ID: 24038869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
